Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

NCT01264341 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
39
Enrollment
OTHER
Sponsor class

Stopped Based on the developments in the treatment of recurrent metastatic renal cancer, the study treatment is no longer considered to be the best treatment option

Conditions

Interventions

Sponsor

Hellenic Cooperative Oncology Group